Reciprocal changes of CD44 and GAP-43 expression in the dentate gyrus inner molecular layer after status epilepticus

Karin Borges1, Dayna L McDermott, Raymond Dingledine

  • 1Department of Pharmacology, Emory University School of Medicine, Atlanta GA 30322, USA. kborges@pharm.emory.edu

Insights

Mossy fiber sprouting (MFS) in epilepsy involves CD44 and GAP-43. Pilocarpine-induced seizures in mice showed CD44 upregulation and GAP-43 loss, correlating with MFS, suggesting CD44

Area of Science:

  • Neuroscience
  • Epilepsy Research
  • Molecular Biology

Background:

  • Mossy fiber sprouting (MFS) is a hallmark of temporal lobe epilepsy, contributing to hyperexcitability.
  • The molecular mechanisms driving MFS are not fully understood, though GAP-43 is implicated.
  • CD44, a hyaluronan receptor, is involved in axonal guidance and upregulated after brain injury.

Purpose of the Study:

  • To investigate the role of CD44 in mossy fiber sprouting following status epilepticus (SE).
  • To examine the relationship between CD44 expression, neuronal loss, and MFS in an epilepsy model.

Main Methods:

  • Induced status epilepticus (SE) in mice using pilocarpine and kainate.
  • Assessed hilar neuron survival using histology.
  • Quantified CD44 and GAP-43 immunoreactivity in the dentate inner molecular layer (IML) via immunohistochemistry.
  • Evaluated mossy fiber sprouting (MFS) by observing Neuropeptide Y (NPY) expression.

Main Results:

  • Pilocarpine-induced SE caused hilar neuron loss, CD44 upregulation, and GAP-43 downregulation in the IML, preceding MFS.
  • Kainate-induced SE, without hilar neuron loss, did not alter CD44 or GAP-43 levels and showed no MFS.
  • Early CD44 induction in the IML correlated with hilar cell loss and subsequent MFS.

Conclusions:

  • CD44 upregulation and GAP-43 downregulation in the IML are associated with hilar neuron loss and MFS after pilocarpine-induced SE.
  • CD44 may play a role in the response to neuronal damage and reorganization preceding MFS.
  • The findings highlight CD44 as a potential early marker and player in epilepsy-associated neuroplasticity.

Related Concept Videos